Testicular Torsion and Risk Factors for Orchiectomy

Total Page:16

File Type:pdf, Size:1020Kb

Testicular Torsion and Risk Factors for Orchiectomy ARTICLE Testicular Torsion and Risk Factors for Orchiectomy Jonathan M. Mansbach, MD; Peter Forbes, MA; Craig Peters, MD Objective: To determine risk factors for testicular loss benign and malignant testicular tumors is 1.2 cases per due to testicular torsion. 100 000. Of the estimated 2248 males diagnosed nation- ally in 1998 with testicular torsion, 762 (34%) had an Design and Participants: Medical records of pa- orchiectomy. In the final multivariate model estimating tients aged 1 to 25 years with a principal diagnosis of tes- the probability of orchiectomy, only age was significant. ticular torsion were extracted from the 1998 Nation- wide Inpatient Sample. Population-based rates of testicular Conclusions: For males aged 1 to 25 years, testicular torsion and orchiectomy were determined. Logistic re- torsion is more common than testicular tumors, and in- gression was used to create a predictive model for orchi- creasing age is the sole identifiable risk factor for orchi- ectomy. For comparison, medical records of patients aged ectomy. We suggest that health care professionals edu- 1 to 25 years with a principal diagnosis of testicular neo- cate prepubertal male patients about testicular torsion plasm were extracted. and the necessity of seeking timely care to reduce the risk of orchiectomy and of possible subsequent reduced Results: The sample comprised 436 participants. The fertility. estimated incidence of testicular torsion for males aged 1 to 25 years in the United States is 4.5 cases per 100 000 male subjects per year, and the estimated incidence of Arch Pediatr Adolesc Med. 2005;159:1167-1171 ESTICULAR TORSION IS A nography is a helpful tool to differentiate urologic emergency. There torsion from other causes of an acutely is approximately a 4- to painful scrotum.5 8-hour window from the Further delays in diagnosis or treat- onset of torsion symptoms ment may be caused by individual pa- until surgical intervention is required to tient factors. Appendicitis is a similar acute T 1 save the affected testis. Delays in care may surgical condition in which delayed diag- necessitate orchiectomy, which has been nosis or delayed surgery may lead to mor- associated with reduced fertility.2 One bidity, specifically rupture of the appen- study3 found that 57% of patients had low dix. In this condition, differences in the sperm counts a median of 5 years after uni- individual patient factors, including in- lateral testicular loss from torsion. surance status and race, have been asso- Providing the necessary medical and ciated with the risk of rupture of the ap- surgical services for a patient with tes- pendix.6,7 The objectives of this study were ticular torsion requires 3 steps, namely, to determine by using a national data- timely presentation, rapid diagnosis, and base if there are identifiable risk factors for curative intervention. The surgical proce- testicular loss due to testicular torsion and dure performed would be orchiectomy to place the epidemiology of testicular tor- for those patients with a nonviable tes- sion in the context of the more com- ticle and septopexy for those with viable monly discussed condition of testicular testes. One potential barrier to providing neoplasm. ideal care is delayed presentation. In fact, male subjects may be hesitant to seek METHODS medical attention for conditions involv- Author Affiliations: Divisions ing their genitals, even for torsion.4 For- of Adolescent/Young Adult tunately, once a patient presents to a The 1998 Nationwide Inpatient Sample (NIS) Medicine (Dr Mansbach) and is part of the Healthcare Cost and Utilization Urology (Dr Peters) and health care professional, the diagnosis of Project, sponsored by the Agency for Health- Clinical Research Program testicular torsion can usually be made care Research and Quality.8 The NIS is a data- (Mr Forbes), Children’s from his history and physical examina- base of hospital inpatient stays, containing data Hospital Boston, Harvard tion. However, when the clinical diagno- from approximately 7 million hospital stays. Medical School, Boston, Mass. sis is uncertain, color Doppler ultraso- The 1998 NIS contains all discharge data from (REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 159, DEC 2005 WWW.ARCHPEDIATRICS.COM 1167 ©2005 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 tered sample design used by the NIS, the SAS Proc Sur- veyMeans was used to compute variances for totals and confi- 400 dence intervals for torsion, orchiectomy, and testicular neoplasm. Cancer (n = 120) Logistic regressions accounted for clustering and stratifica- Torsion (n = 436) tion using SAS Proc SurveyLogistic. 300 Patients with missing covariate levels (Ͻ4% of the total) were included in logistic regression models by assigning them to the majority covariate level. The missing data from the race vari- 200 able were analyzed 3 ways, namely, with the missing data treated as a separate covariate level, with the missing data removed from the analysis, and with the missing data assigned to the major- 100 Cumulative No. of Patients ity covariate level (white race). Race was not significantly as- sociated with orchiectomy no matter how the missing values were assigned. As a result, in the final analyses, missing covar- 0 iates were assigned to the majority covariate level. 1510 15 20 25 The ICD-9-CM code 608.2 includes torsion of the testicle, Age, y appendix testis, and appendix epididymis. It is possible, there- fore, that some patients, most likely the younger ones who had Figure 1. Cumulative number of patients with testicular torsion and with an orchiopexy, did not have torsion of the testicle but rather testicular cancer. torsion of the appendix testis or appendix epididymis. If pa- tients with torsion of the appendix testis or appendix epididy- 984 hospitals located in 22 states, approximating a 20% sample mis had an orchiopexy, these misclassified patients would er- of US community hospitals. The overall goal for the NIS is to roneously lower the percentage of younger males requiring create a sample of hospitals that is generalizable to hospitals orchiectomies. Therefore, a sensitivity analysis was per- in the entire United States. The NIS data set includes a weight formed to determine the potential effect of misclassification on variable for each observation so that a weighted analysis can our conclusions. Under the assumption that some of the young- produce national estimates, with confidence intervals, of total est nonorchiectomy patients could be misclassified (ie, had an cases and rates of procedures of interest. The Children’s Hos- orchiopexy but not torsion of the testicle), random samples of pital Boston Institutional Review Board approved this study. 10%, 33%, and 50% of the nonorchiectomy patients in the Medical records of patients aged 1 to 25 years with the prin- youngest age category were removed, and the relationship be- cipal diagnosis of testicular torsion (International Classifica- tween orchiectomy and age category (youngest vs oldest males) tion of Diseases, Ninth Revision, Clinical Modification [ICD- was reassessed. Although the correct proportion of the nonor- 9-CM] code 608.2) in 1998 were extracted. The ICD-9-CM code chiectomy patients to be removed from the youngest age cat- 608.2 includes torsion of the testicle and torsion of the appen- egory is not known, we anticipate that much fewer than half dix testis and appendix epididymis. We compared the group of these patients, all of whom had a technically unnecessary of patients who received neither orchiectomy nor orchiopexy surgical procedure, had torsion of the appendix epididymis or (n=65) with the group who had a procedure (n=436); the mean appendix testis. ages for the groups were 11.9 vs 15.0 years (PϽ.001). We ex- cluded the 65 patients who did not have a surgical procedure, as these youth most likely had torsion of the appendix testis. RESULTS All 436 patients who had a surgical procedure were included in the analysis. Age-specific census estimates of the US male population were The final sample comprised 436 eligible participants from used to compute rates of testicular torsion and orchiectomy per 231 hospitals in 22 states. The number of torsion cases 100 000 male subjects. The July 1998 US male population aged nationally, estimated using a weighted analysis of the data, 1 to 25 years was extrapolated from census estimates for this was 2248 cases (95% confidence interval [CI], 1950- population at July 1, 2000, and July 1, 2001. For comparison, 2547 cases). Using census results, we estimated the total medical records of patients aged 1 to 25 years with a principal male population aged 1 to 25 years in 1998 to be 50.25 diagnosis of testicular neoplasm (ICD-9-CM codes 186.9 and million. Using these 2 results, the incidence of testicu- 222.0) were also extracted. lar torsion is 4.5 cases (95% CI, 3.9-5.1 cases) per 100 000 Statistical analyses were performed using SAS software ver- male subjects per year in the United States. Within the sion 9 (SAS Institute Inc, Cary, NC). In univariate analyses, t tests and Wilcoxon signed rank tests were used for continu- age range considered, testicular torsion is most com- ous variables, and Fisher exact tests were used for categorical mon in males aged 10 to 19 years, with an incidence of variables. 8.6 cases (95% CI, 7.1-10.1 cases) per 100 000 male sub- Analyses were conducted to determine the effect of differ- jects per year. For comparison, the database contained ent patient- and hospital-specific variables on the risk for or- 120 patients with benign or malignant testicular tu- chiectomy. The patient-specific variables included age (treated mors. Using a weighted analysis, the number of such cases categorically and continuously), race (white, black, or other), nationally was estimated to be 621 cases (95% CI, 300- insurance status (Medicaid, self-pay, or private insurance), and 912 cases).
Recommended publications
  • Guidelines on Paediatric Urology S
    Guidelines on Paediatric Urology S. Tekgül (Chair), H.S. Dogan, E. Erdem (Guidelines Associate), P. Hoebeke, R. Ko˘cvara, J.M. Nijman (Vice-chair), C. Radmayr, M.S. Silay (Guidelines Associate), R. Stein, S. Undre (Guidelines Associate) European Society for Paediatric Urology © European Association of Urology 2015 TABLE OF CONTENTS PAGE 1. INTRODUCTION 7 1.1 Aim 7 1.2 Publication history 7 2. METHODS 8 3. THE GUIDELINE 8 3A PHIMOSIS 8 3A.1 Epidemiology, aetiology and pathophysiology 8 3A.2 Classification systems 8 3A.3 Diagnostic evaluation 8 3A.4 Disease management 8 3A.5 Follow-up 9 3A.6 Conclusions and recommendations on phimosis 9 3B CRYPTORCHIDISM 9 3B.1 Epidemiology, aetiology and pathophysiology 9 3B.2 Classification systems 9 3B.3 Diagnostic evaluation 10 3B.4 Disease management 10 3B.4.1 Medical therapy 10 3B.4.2 Surgery 10 3B.5 Follow-up 11 3B.6 Recommendations for cryptorchidism 11 3C HYDROCELE 12 3C.1 Epidemiology, aetiology and pathophysiology 12 3C.2 Diagnostic evaluation 12 3C.3 Disease management 12 3C.4 Recommendations for the management of hydrocele 12 3D ACUTE SCROTUM IN CHILDREN 13 3D.1 Epidemiology, aetiology and pathophysiology 13 3D.2 Diagnostic evaluation 13 3D.3 Disease management 14 3D.3.1 Epididymitis 14 3D.3.2 Testicular torsion 14 3D.3.3 Surgical treatment 14 3D.4 Follow-up 14 3D.4.1 Fertility 14 3D.4.2 Subfertility 14 3D.4.3 Androgen levels 15 3D.4.4 Testicular cancer 15 3D.5 Recommendations for the treatment of acute scrotum in children 15 3E HYPOSPADIAS 15 3E.1 Epidemiology, aetiology and pathophysiology
    [Show full text]
  • Single Scrotal Incision Orchiopexy - a Systematic Review ______Hugo Fabiano Fernandes Novaes, José Abraão Carneiro Neto, Antonio Macedo Jr, Ubirajara Barroso Júnior
    REVIEW Article Vol. 39 (3): 305-311, May - June, 2013 doi: 10.1590/S1677-5538.IBJU.2013.03.02 Single scrotal incision orchiopexy - a systematic review _______________________________________________ Hugo Fabiano Fernandes Novaes, José Abraão Carneiro Neto, Antonio Macedo Jr, Ubirajara Barroso Júnior Section of Pediatric Urology, Division of Urology Bahiana School of Medicine and Federal University of Bahia and Federal University of São Paulo ABSTRACT ARTICLE INFO _________________________________________________________ ___________________ Objective: To conduct a systematic review on single scrotal incision orchiopexy. Key words: Materials and Methods: A search was performed using Pubmed, through which 16 ar- Cryptorchidism; Orchiopexy; ticles were selected out of a total of 133. The following conditions were considered ex- Scrotum; Surgical Procedures, clusion criteria: other surgical methods such as an inguinal procedure or a laparoscopic Operative approach, retractile testes, or patients with previous testicular or inguinal surgery. Results: A total of 1558 orchiopexy surgeries initiated with a transcrotal incision were Int Braz J Urol. 2013; 39: 305-11 analyzed. Patients’ ages ranged between 5 months and 21 years. Thirteen studies used __________________ high scrotal incisions, and low scrotal incisions were performed in the remainder of the studies. In 55 cases (3.53%), there was a need for inguinal incision. Recurrence was ob- Submitted for publication: served in 9 cases, testicular atrophy in 3, testicular hypotrophy in 2, and surgical site in- December 18, 2012 fections in 13 cases. High efficacy rates were observed, varying between 88% and 100%. __________________ Conclusions: Single scrotal incision orchiopexy proved to be an effective technique and is associated with low rates of complications.
    [Show full text]
  • The History of Microsurgery in Urological Practice
    Chen-1 The History of Microsurgery in Urological Practice Mang L. Chen1, Gregory M. Buncke2 and Paul J. Turek3 1G.U. Recon, San Francisco, CA, 94114 2The Buncke Clinic, San Francisco, CA 94114 3The Turek Clinic, Beverly Hills, CA 90210 Correspondence to: Mang Chen, MD G.U. Recon 45 Castro St, Suite 111 San Francisco, CA 94114 Tel: 415-481-3980 Email: [email protected] Chen-2 Abstract Operative microscopy spans all surgical disciplines, allowing human dexterity to perform beyond direct visual limitations. Microsurgery started in otolaryngology, became popular in reconstructive microsurgery, and was then adopted in urology. Starting with reproductive tract reconstruction of the vas and epididymis, microsurgery in urology now extends to varicocele repair, sperm retrieval, penile transplantation and free flap phalloplasty. By examining the peer reviewed and lay literature this review discusses the history of microsurgery and its subsequent development as a subspecialty in urology. Keywords: urology, microsurgery, phalloplasty, vasovasostomy, varicocelectomy Chen-3 I. Introduction Microsurgery has been instrumental to surgical advances in many medical fields. Otolaryngology, ophthalmology, gynecology, hand and plastic surgery have all embraced the operating microscope to minimize surgical trauma and scar and to increase patency rates of vessels, nerves and tubes. Urologic adoption of microsurgery began with vasectomy reversals, testis transplants, varicocelectomies and sperm retrieval and has now progressed to free flap phalloplasties and penile transplantation. In this review, we describe the origins of microsurgery, highlight the careers of prominent microsurgeons, and discuss current use applications in urology. II. Birth of Microsurgery 1) Technology The birth of microsurgery followed from an interesting marriage of technology and clinical need.
    [Show full text]
  • Answer Key Chapter 1
    Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6.
    [Show full text]
  • Delayed Multiple Port Sites Metastases After Laparoscopic Radical Prostatectomy
    CASE REPORT Delayed Multiple Port Sites Metastases After Laparoscopic Radical Prostatectomy Brusabhanu Nayak, MS, MCH, Prem Nath Dogra, MS, MCH, Vaibhav Saxena, MS, MCH, Ashis Saini, MS, MCH Department of Urology, All India Institute of Medical Sciences, New Delhi, India (all authors). ABSTRACT Introduction: Laparoscopic port site metastases are recurrent nodular lesions developing locally in the abdominal wall within the scar tissue of one or more trocar sites. We are reporting an extremely rare case of delayed multiple port site metastases 3 years after laparoscopic radical prostatectomy. In this case, 3 port site metastases appeared 3 years after laparoscopic radical prostatectomy. Case Description: A 65-year-old man was evaluated for lower urinary tract symptoms and found to have raised serum prostate-specific antigen of 9.06 ng/mL. Transrectal ultrasonography-guided biopsy of the prostate revealed an adeno- carcinoma of the prostate (Gleason score 3 ϩ 4 ϭ 7), with 5 of 12 cores positive for tumor. Contrast-enhanced computed tomography showed localized disease with no involvement of seminal vesicle or lymph nodes. The bone scan was normal. He underwent laparoscopic radical prostatectomy for localized carcinoma of the prostate. He developed 3 port site metastases 3 years after surgery. In view of multiple port site metastatic disease, bilateral orchiectomy was done. The patient is doing well after 1 year of follow-up. Conclusion: We report an occurrence of delayed multiple port site metastases after laparoscopic radical prostatectomy. The 3 sites of metastases in our case included the extraction site, the most active instrument site, and the drain placement site.
    [Show full text]
  • Gender Dysphoria Treatment – Commercial Medical Policy
    UnitedHealthcare® Commercial Medical Policy Gender Dysphoria Treatment Policy Number: 2021T0580J Effective Date: April 1, 2021 Instructions for Use Table of Contents Page Related Commercial Policies Coverage Rationale ....................................................................... 1 • Blepharoplasty, Blepharoptosis and Brow Ptosis Documentation Requirements ...................................................... 3 Repair Definitions ...................................................................................... 4 • Botulinum Toxins A and B Applicable Codes .......................................................................... 5 • Cosmetic and Reconstructive Procedures Description of Services ................................................................. 9 • Gonadotropin Releasing Hormone Analogs Benefit Considerations .................................................................. 9 Clinical Evidence ......................................................................... 10 • Habilitative Services and Outpatient Rehabilitation U.S. Food and Drug Administration ........................................... 15 Therapy References ................................................................................... 15 • Panniculectomy and Body Contouring Procedures Policy History/Revision Information ........................................... 16 • Rhinoplasty and Other Nasal Surgeries Instructions for Use ..................................................................... 17 Community Plan Policy • Gender Dysphoria
    [Show full text]
  • Gender Dysphoria Treatment – Community Plan Medical Policy
    UnitedHealthcare® Community Plan Medical Policy Gender Dysphoria Treatment Policy Number: CS145.I Effective Date: March 1, 2021 Instructions for Use Table of Contents Page Related Community Plan Policies Application ..................................................................................... 1 • Blepharoplasty, Blepharoptosis, and Brow Ptosis Coverage Rationale ....................................................................... 1 Repair Definitions ...................................................................................... 3 • Botulinum Toxins A and B Applicable Codes .......................................................................... 4 • Cosmetic and Reconstructive Procedures Description of Services ................................................................. 8 • Gonadotropin Releasing Hormone Analogs Benefit Considerations .................................................................. 9 Clinical Evidence ........................................................................... 9 • Panniculectomy and Body Contouring Procedures U.S. Food and Drug Administration ........................................... 14 • Rhinoplasty and Other Nasal Surgeries References ................................................................................... 14 • Speech Language Pathology Services Policy History/Revision Information ........................................... 16 Commercial Policy Instructions for Use ..................................................................... 16 • Gender Dysphoria Treatment
    [Show full text]
  • Robotic Surgery for Male Infertility
    Robotic Surgery for Male Infertility Annie Darves-Bornoz, MD, Evan Panken, BS, Robert E. Brannigan, MD, Joshua A. Halpern, MD, MS* KEYWORDS Robotic surgical procedures Infertility Male Vasovasostomy Varicocele KEY POINTS Robotic-assisted approaches to male infertility microsurgery have potential practical benefits including reduction of tremor, 3-dimensional visualization, and decreased need for skilled surgical assistance. Several small, retrospective studies have described robotic-assisted vasectomy reversal with com- parable clinical outcomes to the traditional microsurgical approach. Few studies have described application of the robot to varicocelectomy, testicular sperm extrac- tion, and spermatic cord denervation. The use of robotic-assistance for male infertility procedures is evolving, and adoption has been limited. Rigorous studies are needed to evaluate outcomes and cost-effectiveness. INTRODUCTION with intraperitoneal and pelvic surgery. On the other hand, many of the theoretic and practical ad- Up to 15% of couples have infertility, with approx- 1,2 vantages offered by the robotic approach are imately 50% of cases involving a male factor. A highly transferrable to surgery for male infertility: substantial proportion of men with subfertility have surgically treatable and even reversible etiologies, High quality, 3-dimensional visualization is such as a varicocele or vasal obstruction. The essential for any microsurgical procedure. introduction of the operating microscope revolu- Improved surgeon ergonomics are always desir- tionized the field of male infertility, dramatically able, particularly given the surgeon morbidity improving visualization of small, complex associated with microsurgery.3 anatomic structures. The technical precision Filtering of physiologic tremor can improve pre- afforded has improved operative outcomes across cision during technically demanding micro- the board.
    [Show full text]
  • 2020 Coding and Payment Guide
    MEN’S HEALTH 2020 Coding and Payment Guide This coding reference guide is intended to illustrate the common coding and payment groups for male prosthetic urology and related procedures. This guide is limited to coding and payment for male prosthetic urology procedures performed in the hospital outpatient site-of-service, ambulatory surgery center (ASC) site-of-service and procedures performed by physicians. The rates listed below are reflective of 2020 Medicare national average reimbursement rates and will vary due to geographic adjustment and other factors. These rates are subject to change without notice. 2020 Coding and Payment Guide Effective January 1, 2020 Total Hospital Code Description APC ASC Physicians RVUs Outpatient (Facility) Urinary Sling Procedures Sling operation for correction of male urinary incontinence 53440 5376 $8,067.93 $6.546.11 $784.59 21.74 (e.g., fascia or synthetic) Removal or revision of sling for male incontinence 53442 5375 $4,231.62 $1,976.27 $816.35 22.62 (e.g., fascia or synthetic) Penile Procedures 54110 Excision of penile plaque (Peyronie’s Disease) 5374 $3,018.54 $1,376.97 $650.33 18.02 Excision of penile plaque (Peyronie’s Disease); with graft up 54111 5375 $4,231.62 $1,976.27 $834.03 23.11 to 5 cm in length 54112 Excision of penile plaque (Peyronie’s Disease); with graft > 5 cm in length 5376 $8,067.93 $3,995.65 $976.95 27.07 54360 Plastic operation on penis to correct angulation 5374 $3,018.54 $1,376.97 $751.39 20.82 54400 Insertion of penile prosthesis; non-inflatable (semi-rigid) 5377 $17,573.96
    [Show full text]
  • Individualized Treatment Guidelines for Postpubertal Cryptorchidism
    pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 161-166 http://dx.doi.org/10.5534/wjmh.2015.33.3.161 Review Article Individualized Treatment Guidelines for Postpubertal Cryptorchidism Jae Min Chung1,2, Sang Don Lee1,2 1Department of Urology, Pusan National University School of Medicine, 2Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea Cryptorchidism is a well-known congenital anomaly in children. However, its diagnosis is often delayed for reasons including patient unawareness or denial of abnormal findings in the testis. Moreover, it has been difficult to establish an optimal treatment strategy for postpubertal cryptorchidism, given the small number of patients. Unlike cryptorchidism in children, postpubertal cryptorchidism is associated with an increased probability of neoplasms, which has led orchiectomy to be the recommended treatment. However, routine orchiectomy should be avoided in some cases due to quality-of-life issues and the potential risk of perioperative mortality. Based on a literature review, this study proposes individualized treatment guidelines for postpubertal cryptorchidism. Key Words: Adolescent; Adult; Cryptorchidism INTRODUCTION egies for cryptorchidism in children are well-established. A surgical approach, most often orchiopexy, is recom- Cryptorchidism is a pathological condition in which the mended for testes that remain undescended after six testis fails to descend to the base of the scrotum. It is one months of age [3]. However, it has been difficult to estab- of the most common congenital anomalies encountered in lish a standard treatment for postpubertal cryptorchidism, pediatric urology. Despite extensive study, knowledge re- given the small number of patients with this condition.
    [Show full text]
  • Standards for Oncology Registry Entry STORE 2018
    STandards for Oncology Registry Entry STORE 2018 Effective for Cases Diagnosed January 1, 2018 STORE STandards for Oncology Registry Entry Released 2018 (Incorporates all updates to Commission on Cancer, National Cancer Database Data standards since FORDS was revised in 2016) Effective for cases diagnosed January 1, 2018 See Appendix A for Updates since FORDS: Revised for 2016. Version 1.0 © 2018 AMERICAN COLLEGE OF SURGEONS All Rights Reserved STORE 2018 Table of Contents Table of Contents Table of Contents ......................................................................................................................... ii Foreword ..................................................................................................................................... 1 FROM “FORDS” TO “STORE” ..................................................................................................................... 1 Preface 2018 ................................................................................................................................ 2 Comorbidities and Complications ............................................................................................................. 2 Revisions to Staging Requirements ........................................................................................................... 2 Staging Data Items No Longer Required for Cases Diagnosed in 2018 and Later (Required for Cases Diagnosed 2017 and Earlier) ................................................................................................................
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]